1
|
Ruch F, Gnörich J, Wind K, Köhler M, Zatcepin A, Wiedemann T, Gildehaus FJ, Lindner S, Boening G, von Ungern-Sternberg B, Beyer L, Herms J, Bartenstein P, Brendel M, Eckenweber F. Validity and value of metabolic connectivity in mouse models of β-amyloid and tauopathy. Neuroimage 2024; 286:120513. [PMID: 38191101 DOI: 10.1016/j.neuroimage.2024.120513] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2023] [Revised: 08/25/2023] [Accepted: 01/05/2024] [Indexed: 01/10/2024] Open
Abstract
Among functional imaging methods, metabolic connectivity (MC) is increasingly used for investigation of regional network changes to examine the pathophysiology of neurodegenerative diseases such as Alzheimer's disease (AD) or movement disorders. Hitherto, MC was mostly used in clinical studies, but only a few studies demonstrated the usefulness of MC in the rodent brain. The goal of the current work was to analyze and validate metabolic regional network alterations in three different mouse models of neurodegenerative diseases (β-amyloid and tau) by use of 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography (FDG-PET) imaging. We compared the results of FDG-µPET MC with conventional VOI-based analysis and behavioral assessment in the Morris water maze (MWM). The impact of awake versus anesthesia conditions on MC read-outs was studied and the robustness of MC data deriving from different scanners was tested. MC proved to be an accurate and robust indicator of functional connectivity loss when sample sizes ≥12 were considered. MC readouts were robust across scanners and in awake/ anesthesia conditions. MC loss was observed throughout all brain regions in tauopathy mice, whereas β-amyloid indicated MC loss mainly in spatial learning areas and subcortical networks. This study established a methodological basis for the utilization of MC in different β-amyloid and tau mouse models. MC has the potential to serve as a read-out of pathological changes within neuronal networks in these models.
Collapse
Affiliation(s)
- François Ruch
- Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany
| | - Johannes Gnörich
- Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
| | - Karin Wind
- Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
| | - Mara Köhler
- Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany
| | - Artem Zatcepin
- Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
| | - Thomas Wiedemann
- Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany
| | - Franz-Joseph Gildehaus
- Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany
| | - Simon Lindner
- Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany
| | - Guido Boening
- Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany
| | | | - Leonie Beyer
- Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany
| | - Jochen Herms
- German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany; Center of Neuropathology and Prion Research, University of Munich, Munich, Germany
| | - Peter Bartenstein
- Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
| | - Matthias Brendel
- Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
| | - Florian Eckenweber
- Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany
| |
Collapse
|
2
|
Hinsen P, Wiedemann T, Shutin D, Lilienthal AJ. Exploration and Gas Source Localization in Advection-Diffusion Processes with Potential-Field-Controlled Robotic Swarms. Sensors (Basel) 2023; 23:9232. [PMID: 38005618 PMCID: PMC10674467 DOI: 10.3390/s23229232] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/02/2023] [Revised: 11/08/2023] [Accepted: 11/09/2023] [Indexed: 11/26/2023]
Abstract
Mobile multi-robot systems are well suited for gas leak localization in challenging environments. They offer inherent advantages such as redundancy, scalability, and resilience to hazardous environments, all while enabling autonomous operation, which is key to efficient swarm exploration. To efficiently localize gas sources using concentration measurements, robots need to seek out informative sampling locations. For this, domain knowledge needs to be incorporated into their exploration strategy. We achieve this by means of partial differential equations incorporated into a probabilistic gas dispersion model that is used to generate a spatial uncertainty map of process parameters. Previously, we presented a potential-field-control approach for navigation based on this map. We build upon this work by considering a more realistic gas dispersion model, now taking into account the mechanism of advection, and dynamics of the gas concentration field. The proposed extension is evaluated through extensive simulations. We find that introducing fluctuations in the wind direction makes source localization a fundamentally harder problem to solve. Nevertheless, the proposed approach can recover the gas source distribution and compete with a systematic sampling strategy. The estimator we present in this work is able to robustly recover source candidates within only a few seconds. Larger swarms are able to reduce total uncertainty faster. Our findings emphasize the applicability and robustness of robotic swarm exploration in dynamic and challenging environments for tasks such as gas source localization.
Collapse
Affiliation(s)
- Patrick Hinsen
- Institute of Communications and Navigation, German Aerospace Center (DLR), 82234 Wessling, Germany; (T.W.); (D.S.)
| | - Thomas Wiedemann
- Institute of Communications and Navigation, German Aerospace Center (DLR), 82234 Wessling, Germany; (T.W.); (D.S.)
| | - Dmitriy Shutin
- Institute of Communications and Navigation, German Aerospace Center (DLR), 82234 Wessling, Germany; (T.W.); (D.S.)
| | - Achim J. Lilienthal
- Chair of Perception for Intelligent Systems, School of Computation, Information and Technology (CIT), Technical University of Munich (TUM), 80992 Munich, Germany;
| |
Collapse
|
3
|
Gnörich J, Reifschneider A, Wind K, Zatcepin A, Kunte ST, Beumers P, Bartos LM, Wiedemann T, Grosch M, Xiang X, Fard MK, Ruch F, Werner G, Koehler M, Slemann L, Hummel S, Briel N, Blume T, Shi Y, Biechele G, Beyer L, Eckenweber F, Scheifele M, Bartenstein P, Albert NL, Herms J, Tahirovic S, Haass C, Capell A, Ziegler S, Brendel M. Depletion and activation of microglia impact metabolic connectivity of the mouse brain. J Neuroinflammation 2023; 20:47. [PMID: 36829182 PMCID: PMC9951492 DOI: 10.1186/s12974-023-02735-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2022] [Accepted: 02/13/2023] [Indexed: 02/26/2023] Open
Abstract
AIM We aimed to investigate the impact of microglial activity and microglial FDG uptake on metabolic connectivity, since microglial activation states determine FDG-PET alterations. Metabolic connectivity refers to a concept of interacting metabolic brain regions and receives growing interest in approaching complex cerebral metabolic networks in neurodegenerative diseases. However, underlying sources of metabolic connectivity remain to be elucidated. MATERIALS AND METHODS We analyzed metabolic networks measured by interregional correlation coefficients (ICCs) of FDG-PET scans in WT mice and in mice with mutations in progranulin (Grn) or triggering receptor expressed on myeloid cells 2 (Trem2) knockouts (-/-) as well as in double mutant Grn-/-/Trem2-/- mice. We selected those rodent models as they represent opposite microglial signatures with disease associated microglia in Grn-/- mice and microglia locked in a homeostatic state in Trem2-/- mice; however, both resulting in lower glucose uptake of the brain. The direct influence of microglia on metabolic networks was further determined by microglia depletion using a CSF1R inhibitor in WT mice at two different ages. Within maps of global mean scaled regional FDG uptake, 24 pre-established volumes of interest were applied and assigned to either cortical or subcortical networks. ICCs of all region pairs were calculated and z-transformed prior to group comparisons. FDG uptake of neurons, microglia, and astrocytes was determined in Grn-/- and WT mice via assessment of single cell tracer uptake (scRadiotracing). RESULTS Microglia depletion by CSF1R inhibition resulted in a strong decrease of metabolic connectivity defined by decrease of mean cortical ICCs in WT mice at both ages studied (6-7 m; p = 0.0148, 9-10 m; p = 0.0191), when compared to vehicle-treated age-matched WT mice. Grn-/-, Trem2-/- and Grn-/-/Trem2-/- mice all displayed reduced FDG-PET signals when compared to WT mice. However, when analyzing metabolic networks, a distinct increase of ICCs was observed in Grn-/- mice when compared to WT mice in cortical (p < 0.0001) and hippocampal (p < 0.0001) networks. In contrast, Trem2-/- mice did not show significant alterations in metabolic connectivity when compared to WT. Furthermore, the increased metabolic connectivity in Grn-/- mice was completely suppressed in Grn-/-/Trem2-/- mice. Grn-/- mice exhibited a severe loss of neuronal FDG uptake (- 61%, p < 0.0001) which shifted allocation of cellular brain FDG uptake to microglia (42% in Grn-/- vs. 22% in WT). CONCLUSIONS Presence, absence, and activation of microglia have a strong impact on metabolic connectivity of the mouse brain. Enhanced metabolic connectivity is associated with increased microglial FDG allocation.
Collapse
Affiliation(s)
- Johannes Gnörich
- grid.5252.00000 0004 1936 973XDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377 Munich, Germany ,grid.424247.30000 0004 0438 0426German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
| | - Anika Reifschneider
- grid.5252.00000 0004 1936 973XMetabolic Biochemistry, Faculty of Medicine, Biomedical Center (BMC), Ludwig-Maximilians-Universität München, Munich, Germany
| | - Karin Wind
- grid.5252.00000 0004 1936 973XDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377 Munich, Germany ,grid.424247.30000 0004 0438 0426German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
| | - Artem Zatcepin
- grid.5252.00000 0004 1936 973XDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377 Munich, Germany ,grid.424247.30000 0004 0438 0426German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
| | - Sebastian T. Kunte
- grid.5252.00000 0004 1936 973XDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377 Munich, Germany
| | - Philipp Beumers
- grid.5252.00000 0004 1936 973XDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377 Munich, Germany
| | - Laura M. Bartos
- grid.5252.00000 0004 1936 973XDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377 Munich, Germany
| | - Thomas Wiedemann
- grid.5252.00000 0004 1936 973XMetabolic Biochemistry, Faculty of Medicine, Biomedical Center (BMC), Ludwig-Maximilians-Universität München, Munich, Germany
| | - Maximilian Grosch
- grid.5252.00000 0004 1936 973XGerman Center for Vertigo and Balance Disorders, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
| | - Xianyuan Xiang
- grid.5252.00000 0004 1936 973XMetabolic Biochemistry, Faculty of Medicine, Biomedical Center (BMC), Ludwig-Maximilians-Universität München, Munich, Germany ,grid.9227.e0000000119573309CAS Key Laboratory of Brain Connectome and Manipulation, The Brain Cognition and Brain Disease Institute, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions, Shenzhen, 518055 China
| | - Maryam K. Fard
- grid.424247.30000 0004 0438 0426German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
| | - Francois Ruch
- grid.5252.00000 0004 1936 973XDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377 Munich, Germany
| | - Georg Werner
- grid.5252.00000 0004 1936 973XMetabolic Biochemistry, Faculty of Medicine, Biomedical Center (BMC), Ludwig-Maximilians-Universität München, Munich, Germany
| | - Mara Koehler
- grid.5252.00000 0004 1936 973XDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377 Munich, Germany
| | - Luna Slemann
- grid.5252.00000 0004 1936 973XDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377 Munich, Germany
| | - Selina Hummel
- grid.5252.00000 0004 1936 973XDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377 Munich, Germany
| | - Nils Briel
- grid.424247.30000 0004 0438 0426German Center for Neurodegenerative Diseases (DZNE), Munich, Germany ,grid.5252.00000 0004 1936 973XCenter for Neuropathology and Prion Research, Ludwig-Maximilians-Universität München, Munich, Germany
| | - Tanja Blume
- grid.424247.30000 0004 0438 0426German Center for Neurodegenerative Diseases (DZNE), Munich, Germany ,grid.5252.00000 0004 1936 973XCenter for Neuropathology and Prion Research, Ludwig-Maximilians-Universität München, Munich, Germany
| | - Yuan Shi
- grid.424247.30000 0004 0438 0426German Center for Neurodegenerative Diseases (DZNE), Munich, Germany ,grid.5252.00000 0004 1936 973XCenter for Neuropathology and Prion Research, Ludwig-Maximilians-Universität München, Munich, Germany
| | - Gloria Biechele
- grid.5252.00000 0004 1936 973XDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377 Munich, Germany
| | - Leonie Beyer
- grid.5252.00000 0004 1936 973XDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377 Munich, Germany
| | - Florian Eckenweber
- grid.5252.00000 0004 1936 973XDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377 Munich, Germany
| | - Maximilian Scheifele
- grid.5252.00000 0004 1936 973XDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377 Munich, Germany
| | - Peter Bartenstein
- grid.5252.00000 0004 1936 973XDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377 Munich, Germany ,grid.452617.3Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
| | - Nathalie L. Albert
- grid.5252.00000 0004 1936 973XDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377 Munich, Germany
| | - Jochen Herms
- grid.424247.30000 0004 0438 0426German Center for Neurodegenerative Diseases (DZNE), Munich, Germany ,grid.5252.00000 0004 1936 973XCenter for Neuropathology and Prion Research, Ludwig-Maximilians-Universität München, Munich, Germany ,grid.452617.3Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
| | - Sabina Tahirovic
- grid.424247.30000 0004 0438 0426German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
| | - Christian Haass
- grid.424247.30000 0004 0438 0426German Center for Neurodegenerative Diseases (DZNE), Munich, Germany ,grid.5252.00000 0004 1936 973XMetabolic Biochemistry, Faculty of Medicine, Biomedical Center (BMC), Ludwig-Maximilians-Universität München, Munich, Germany ,grid.452617.3Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
| | - Anja Capell
- grid.5252.00000 0004 1936 973XMetabolic Biochemistry, Faculty of Medicine, Biomedical Center (BMC), Ludwig-Maximilians-Universität München, Munich, Germany
| | - Sibylle Ziegler
- grid.5252.00000 0004 1936 973XDepartment of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377 Munich, Germany ,grid.452617.3Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
| | - Matthias Brendel
- Department of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377, Munich, Germany. .,German Center for Neurodegenerative Diseases (DZNE), Munich, Germany. .,Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
| |
Collapse
|
4
|
Xiang X, Wind K, Wiedemann T, Blume T, Shi Y, Briel N, Beyer L, Biechele G, Eckenweber F, Zatcepin A, Lammich S, Ribicic S, Tahirovic S, Willem M, Deussing M, Palleis C, Rauchmann BS, Gildehaus FJ, Lindner S, Spitz C, Franzmeier N, Baumann K, Rominger A, Bartenstein P, Ziegler S, Drzezga A, Respondek G, Buerger K, Perneczky R, Levin J, Höglinger GU, Herms J, Haass C, Brendel M. Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases. Sci Transl Med 2021; 13:eabe5640. [PMID: 34644146 DOI: 10.1126/scitranslmed.abe5640] [Citation(s) in RCA: 86] [Impact Index Per Article: 28.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
2-Deoxy-2-[18F]fluoro-d-glucose positron emission tomography (FDG-PET) is widely used to study cerebral glucose metabolism. Here, we investigated whether the FDG-PET signal is directly influenced by microglial glucose uptake in mouse models and patients with neurodegenerative diseases. Using a recently developed approach for cell sorting after FDG injection, we found that, at cellular resolution, microglia displayed higher glucose uptake than neurons and astrocytes. Alterations in microglial glucose uptake were responsible for both the FDG-PET signal decrease in Trem2-deficient mice and the FDG-PET signal increase in mouse models for amyloidosis. Thus, opposite microglial activation states determine the differential FDG uptake. Consistently, 12 patients with Alzheimer’s disease and 21 patients with four-repeat tauopathies also exhibited a positive association between glucose uptake and microglial activity as determined by 18F-GE-180 18-kDa translocator protein PET (TSPO-PET) in preserved brain regions, indicating that the cerebral glucose uptake in humans is also strongly influenced by microglial activity. Our findings suggest that microglia activation states are responsible for FDG-PET signal alterations in patients with neurodegenerative diseases and mouse models for amyloidosis. Microglial activation states should therefore be considered when performing FDG-PET.
Collapse
Affiliation(s)
- Xianyuan Xiang
- Biomedical Center (BMC), Division of Metabolic Biochemistry, Faculty of Medicine, Ludwig-Maximilians-Universität München, 81377 Munich, Germany
- CAS Key Laboratory of Brain Connectome and Manipulation, Brain Cognition and Brain Disease Institute, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences; Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions, 518055 Shenzhen, China
| | - Karin Wind
- Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, 81377 Munich, Germany
- German Center for Neurodegenerative Diseases (DZNE) Munich, 81377 Munich, Germany
| | - Thomas Wiedemann
- Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, 81377 Munich, Germany
| | - Tanja Blume
- Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, 81377 Munich, Germany
- German Center for Neurodegenerative Diseases (DZNE) Munich, 81377 Munich, Germany
| | - Yuan Shi
- German Center for Neurodegenerative Diseases (DZNE) Munich, 81377 Munich, Germany
| | - Nils Briel
- German Center for Neurodegenerative Diseases (DZNE) Munich, 81377 Munich, Germany
- Center for Neuropathology and Prion Research, Ludwig-Maximilians-University München, 81377 Munich, Germany
| | - Leonie Beyer
- Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, 81377 Munich, Germany
| | - Gloria Biechele
- Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, 81377 Munich, Germany
| | - Florian Eckenweber
- Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, 81377 Munich, Germany
| | - Artem Zatcepin
- Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, 81377 Munich, Germany
- German Center for Neurodegenerative Diseases (DZNE) Munich, 81377 Munich, Germany
| | - Sven Lammich
- Biomedical Center (BMC), Division of Metabolic Biochemistry, Faculty of Medicine, Ludwig-Maximilians-Universität München, 81377 Munich, Germany
| | - Sara Ribicic
- German Center for Neurodegenerative Diseases (DZNE) Munich, 81377 Munich, Germany
| | - Sabina Tahirovic
- German Center for Neurodegenerative Diseases (DZNE) Munich, 81377 Munich, Germany
| | - Michael Willem
- Biomedical Center (BMC), Division of Metabolic Biochemistry, Faculty of Medicine, Ludwig-Maximilians-Universität München, 81377 Munich, Germany
| | - Maximilian Deussing
- Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, 81377 Munich, Germany
| | - Carla Palleis
- German Center for Neurodegenerative Diseases (DZNE) Munich, 81377 Munich, Germany
- Department of Neurology, University Hospital of Munich, LMU Munich, 81377 Munich, Germany
| | - Boris-Stephan Rauchmann
- Department of Radiology, University Hospital of Munich, LMU Munich, 81377 Munich, Germany
- Department of Psychiatry and Psychotherapy, University Hospital of Munich, LMU Munich, 81377 Munich, Germany
| | - Franz-Josef Gildehaus
- Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, 81377 Munich, Germany
| | - Simon Lindner
- Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, 81377 Munich, Germany
| | - Charlotte Spitz
- Institute of Biochemistry and Molecular Biology, University of Augsburg, 86159 Augsburg, Germany
| | - Nicolai Franzmeier
- Institute for Stroke and Dementia Research (ISD), University Hospital of Munich, LMU Munich, 81377 Munich, Germany
| | - Karlheinz Baumann
- Roche, Pharma Research and Early Development, NORD DTA/Neuroscience Discovery, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, Switzerland
| | - Axel Rominger
- Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, 81377 Munich, Germany
- Department of Nuclear Medicine, University of Bern, Inselspital, CH-3010 Bern, Switzerland
| | - Peter Bartenstein
- Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, 81377 Munich, Germany
- Munich Cluster for Systems Neurology (SyNergy), 81377 Munich, Germany
| | - Sibylle Ziegler
- Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, 81377 Munich, Germany
- Munich Cluster for Systems Neurology (SyNergy), 81377 Munich, Germany
| | - Alexander Drzezga
- Department of Nuclear Medicine, Faculty of Medicine, University Hospital Cologne, University of Cologne, 5091 Cologne, Germany
- German Center for Neurodegenerative Diseases (DZNE) Bonn-Cologne, 53127 Bonn, Germany
- Institute of Neuroscience and Medicine (INM-2), Molecular Organization of the Brain, Forschungszentrum Jülich, 52425 Jülich, Germany
| | - Gesine Respondek
- Department of Neurology, Hannover Medical School, 30625 Hannover, Germany
| | - Katharina Buerger
- German Center for Neurodegenerative Diseases (DZNE) Munich, 81377 Munich, Germany
- Institute for Stroke and Dementia Research (ISD), University Hospital of Munich, LMU Munich, 81377 Munich, Germany
| | - Robert Perneczky
- German Center for Neurodegenerative Diseases (DZNE) Munich, 81377 Munich, Germany
- Department of Psychiatry and Psychotherapy, University Hospital of Munich, LMU Munich, 81377 Munich, Germany
- Munich Cluster for Systems Neurology (SyNergy), 81377 Munich, Germany
- Ageing Epidemiology (AGE) Research Unit, School of Public Health, Imperial College, London SW7 2AZ, UK
| | - Johannes Levin
- German Center for Neurodegenerative Diseases (DZNE) Munich, 81377 Munich, Germany
- Department of Neurology, University Hospital of Munich, LMU Munich, 81377 Munich, Germany
- Munich Cluster for Systems Neurology (SyNergy), 81377 Munich, Germany
| | - Günter U Höglinger
- German Center for Neurodegenerative Diseases (DZNE) Munich, 81377 Munich, Germany
- Munich Cluster for Systems Neurology (SyNergy), 81377 Munich, Germany
- Department of Neurology, Hannover Medical School, 30625 Hannover, Germany
- Department of Neurology, Technical University Munich, 81675 Munich, Germany
| | - Jochen Herms
- German Center for Neurodegenerative Diseases (DZNE) Munich, 81377 Munich, Germany
- Center for Neuropathology and Prion Research, Ludwig-Maximilians-University München, 81377 Munich, Germany
- Munich Cluster for Systems Neurology (SyNergy), 81377 Munich, Germany
| | - Christian Haass
- Biomedical Center (BMC), Division of Metabolic Biochemistry, Faculty of Medicine, Ludwig-Maximilians-Universität München, 81377 Munich, Germany
- German Center for Neurodegenerative Diseases (DZNE) Munich, 81377 Munich, Germany
- Munich Cluster for Systems Neurology (SyNergy), 81377 Munich, Germany
| | - Matthias Brendel
- Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, 81377 Munich, Germany
- German Center for Neurodegenerative Diseases (DZNE) Munich, 81377 Munich, Germany
- Munich Cluster for Systems Neurology (SyNergy), 81377 Munich, Germany
| |
Collapse
|
5
|
Viseras A, Wiedemann T, Manss C, Karolj V, And Juan Marchal DS. Beehive-Inspired Information Gathering with a Swarm of Autonomous Drones. Sensors (Basel) 2019; 19:s19194349. [PMID: 31597338 PMCID: PMC6806085 DOI: 10.3390/s19194349] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/30/2019] [Revised: 09/27/2019] [Accepted: 10/05/2019] [Indexed: 11/16/2022]
Abstract
This paper presents a beehive-inspired multi-agent drone system for autonomous information collection to support the needs of first responders and emergency teams. The proposed system is designed to be simple, cost-efficient, yet robust and scalable at the same time. It includes several unmanned aerial vehicles (UAVs) that can be tasked with data collection, and a single control station that acts as a data accumulation and visualization unit. The system also provides a local communication access point for the UAVs to exchange information and coordinate the data collection routes. By avoiding peer-to-peer communication and using proactive collision avoidance and path-planning, the payload weight and per-drone costs can be significantly reduced; the whole concept can be implemented using inexpensive off-the-shelf components. Moreover, the proposed concept can be used with different sensors and types of UAVs. As such, it is suited for local-area operations, but also for large-scale information-gathering scenarios. The paper outlines the details of the system hardware and software design, and discusses experimental results for collecting image information with a set of 4 multirotor UAVs at a small experimental area. The obtained results validate the concept and demonstrate robustness and scalability of the system.
Collapse
Affiliation(s)
- Alberto Viseras
- German Aerospace Center (DLR), Oberpfaffenhofen, 82234 Weßling, Germany.
| | - Thomas Wiedemann
- German Aerospace Center (DLR), Oberpfaffenhofen, 82234 Weßling, Germany.
| | - Christoph Manss
- German Aerospace Center (DLR), Oberpfaffenhofen, 82234 Weßling, Germany.
| | - Valentina Karolj
- German Aerospace Center (DLR), Oberpfaffenhofen, 82234 Weßling, Germany.
| | | |
Collapse
|
6
|
Khoja F, Eriguel J, Wiedemann T, Talib H. Oral Malignancy Mimicking Peri-Implantitis: A Clinical Dilemma. J Oral Maxillofac Surg 2019. [DOI: 10.1016/j.joms.2019.06.095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
7
|
Hernandez Bennetts V, Kamarudin K, Wiedemann T, Kucner TP, Somisetty SL, Lilienthal AJ. Multi-Domain Airflow Modeling and Ventilation Characterization Using Mobile Robots, Stationary Sensors and Machine Learning. Sensors (Basel) 2019; 19:s19051119. [PMID: 30841615 PMCID: PMC6427329 DOI: 10.3390/s19051119] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/07/2018] [Revised: 02/18/2019] [Accepted: 02/26/2019] [Indexed: 11/26/2022]
Abstract
Ventilation systems are critically important components of many public buildings and workspaces. Proper ventilation is often crucial for preventing accidents, such as explosions in mines and avoiding health issues, for example, through long-term exposure to harmful respirable matter. Validation and maintenance of ventilation systems is thus of key interest for plant operators and authorities. However, methods for ventilation characterization, which allow us to monitor whether the ventilation system in place works as desired, hardly exist. This article addresses the critical challenge of ventilation characterization—measuring and modelling air flow at micro-scales—that is, creating a high-resolution model of wind speed and direction from airflow measurements. Models of the near-surface micro-scale flow fields are not only useful for ventilation characterization, but they also provide critical information for planning energy-efficient paths for aerial robots and many applications in mobile robot olfaction. In this article we propose a heterogeneous measurement system composed of static, continuously sampling sensing nodes, complemented by localized measurements, collected during occasional sensing missions with a mobile robot. We introduce a novel, data-driven, multi-domain airflow modelling algorithm that estimates (1) fields of posterior distributions over wind direction and speed (“ventilation maps”, spatial domain); (2) sets of ventilation calendars that capture the evolution of important airflow characteristics at measurement positions (temporal domain); and (3) a frequency domain analysis that can reveal periodic changes of airflow in the environment. The ventilation map and the ventilation calendars make use of an improved estimation pipeline that incorporates a wind sensor model and a transition model to better filter out sporadic, noisy airflow changes. These sudden changes may originate from turbulence or irregular activity in the surveyed environment and can, therefore, disturb modelling of the relevant airflow patterns. We tested the proposed multi-domain airflow modelling approach with simulated data and with experiments in a semi-controlled environment and present results that verify the accuracy of our approach and its sensitivity to different turbulence levels and other disturbances. Finally, we deployed the proposed system in two different real-world industrial environments (foundry halls) with different ventilation regimes for three weeks during full operation. Since airflow ground truth cannot be obtained, we present a qualitative discussion of the generated airflow models with plant operators, who concluded that the computed models accurately depicted the expected airflow patterns and are useful to understand how pollutants spread in the work environment. This analysis may then provide the basis for decisions about corrective actions to avoid long-term exposure of workers to harmful respirable matter.
Collapse
Affiliation(s)
| | - Kamarulzaman Kamarudin
- Center of Excellence for Advanced Sensor Technology, School of Mechatronics Engineering, Universiti Malaysia Perlis, Arau Perlis 02600, Malaysia.
| | - Thomas Wiedemann
- Institute of Communications and Navigation, German Aerospace Center, 82234 Oberpfaffenhofen, Germany.
| | - Tomasz Piotr Kucner
- Mobile Robotics and Olfaction Lab, Örebro University, 702 81 Örebro, Sweden.
| | | | - Achim J Lilienthal
- Mobile Robotics and Olfaction Lab, Örebro University, 702 81 Örebro, Sweden.
| |
Collapse
|
8
|
Wiedemann T, Lilienthal AJ, Shutin D. Analysis of Model Mismatch Effects for a Model-Based Gas Source Localization Strategy Incorporating Advection Knowledge. Sensors (Basel) 2019; 19:s19030520. [PMID: 30691174 PMCID: PMC6387390 DOI: 10.3390/s19030520] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/09/2018] [Revised: 01/19/2019] [Accepted: 01/21/2019] [Indexed: 11/29/2022]
Abstract
In disaster scenarios, where toxic material is leaking, gas source localization is a common but also dangerous task. To reduce threats for human operators, we propose an intelligent sampling strategy that enables a multi-robot system to autonomously localize unknown gas sources based on gas concentration measurements. This paper discusses a probabilistic, model-based approach for incorporating physical process knowledge into the sampling strategy. We model the spatial and temporal dynamics of the gas dispersion with a partial differential equation that accounts for diffusion and advection effects. We consider the exact number of sources as unknown, but assume that gas sources are sparsely distributed. To incorporate the sparsity assumption we make use of sparse Bayesian learning techniques. Probabilistic modeling can account for possible model mismatch effects that otherwise can undermine the performance of deterministic methods. In the paper we evaluate the proposed gas source localization strategy in simulations using synthetic data. Compared to real-world experiments, a simulated environment provides us with ground truth data and reproducibility necessary to get a deeper insight into the proposed strategy. The investigation shows that (i) the probabilistic model can compensate imperfect modeling; (ii) the sparsity assumption significantly accelerates the source localization; and (iii) a-priori advection knowledge is of advantage for source localization, however, it is only required to have a certain level of accuracy. These findings will help in the future to parameterize the proposed algorithm in real world applications.
Collapse
Affiliation(s)
| | - Achim J Lilienthal
- Centre for Applied Autonomous Sensor Systems, Örebro University, 70182 Örebro, Sweden.
| | - Dmitriy Shutin
- German Aerospace Center, 82234 Oberpfaffenhofen, Germany.
| |
Collapse
|
9
|
Abstract
AbstractTumor documentation is an important task for both clinical research and patient care. Documentation systems for these purposes have to be planned systematically and should be goal oriented. We applied the method of a so-called ‘standardized documentation protocol’ for systematically planning two documentation systems in oncology: one for the tumor center Heidelberg/Mannheim and the other for a nationwide project in the field of documentation and therapy planning in pediatric oncology. The method proved to be helpful in both cases even though the resulting documentation protocols are completely different and although they served different objectives. Therefore, the aim of the paper is to motivate and help medical informatics professionals to systematically plan other documentation systems using this method.
Collapse
|
10
|
Falivene L, Wiedemann T, Göttker-Schnetmann I, Caporaso L, Cavallo L, Mecking S. Control of Chain Walking by Weak Neighboring Group Interactions in Unsymmetrical Catalysts. J Am Chem Soc 2018; 140:1305-1312. [DOI: 10.1021/jacs.7b08975] [Citation(s) in RCA: 59] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Affiliation(s)
- Laura Falivene
- King
Abdullah University of Science and Technology, Chemical and Life Sciences
and Engineering, Kaust Catalysis Center, Thuwal 23955-6900, Saudi Arabia
| | - Thomas Wiedemann
- Chair of Chemical Materials Science, Department of Chemistry, University of Konstanz, 78464 Konstanz, Germany
| | - Inigo Göttker-Schnetmann
- Chair of Chemical Materials Science, Department of Chemistry, University of Konstanz, 78464 Konstanz, Germany
| | - Lucia Caporaso
- Department
of Chemistry, University of Salerno, Via Giovanni Paolo II, 84084 Fisciano (SA), Italy
| | - Luigi Cavallo
- King
Abdullah University of Science and Technology, Chemical and Life Sciences
and Engineering, Kaust Catalysis Center, Thuwal 23955-6900, Saudi Arabia
| | - Stefan Mecking
- Chair of Chemical Materials Science, Department of Chemistry, University of Konstanz, 78464 Konstanz, Germany
| |
Collapse
|
11
|
Wiedemann T, Bielohuby M, Müller TD, Bidlingmaier M, Pellegata NS. Islet Hyperplasia and Hyperghrelinemia in p27 deficient (MENX) rats. DIABETOL STOFFWECHS 2016. [DOI: 10.1055/s-0036-1580920] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
12
|
Wiedemann T, Voit G, Tchernook A, Roesle P, Göttker-Schnetmann I, Mecking S. Monofunctional Hyperbranched Ethylene Oligomers. J Am Chem Soc 2014; 136:2078-85. [DOI: 10.1021/ja411945n] [Citation(s) in RCA: 106] [Impact Index Per Article: 10.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Affiliation(s)
- Thomas Wiedemann
- Chair of Chemical Materials Science, Department of Chemistry, University of Konstanz , 78464 Konstanz, Germany
| | | | | | | | | | | |
Collapse
|
13
|
|
14
|
Weber R, Knaup P, Knietitg R, Haux R, Merzweiler A, Mludek V, Schilling FH, Wiedemann T. Object-oriented business process analysis of the cooperative soft tissue sarcoma trial of the german society for paediatric oncology and haematology (GPOH). Stud Health Technol Inform 2002; 84:58-62. [PMID: 11604706] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/21/2023]
Abstract
The German Society for Paediatric Oncology and Haematology (GPOH) runs nation-wide multicentre clinical trials to improve the treatment of children suffering from malignant diseases. We want to provide methods and tools to support the centres of these trials in developing trial specific modules for the computer-based DOcumentation System for Paediatric Oncology (DOSPO). For this we carried out an object-oriented business process analysis for the Cooperative Soft Tissue Sarcoma Trial at the Olgahospital Stuttgart for Child and Adolescent Medicine. The result is a comprehensive business process model consisting of UML-diagrams and use case specifications. We recommend the object-oriented business process analysis as a method for the definition of requirements in information processing projects in the field of clinical trials in general. For this our model can serve as basis because it slightly can be adjusted to each type of clinical trial.
Collapse
Affiliation(s)
- R Weber
- Institute for Medical Biometry and Informatics, Department of Medical Informatics, University of Heidelberg, 69120 Heidelberg, Germany.
| | | | | | | | | | | | | | | |
Collapse
|
15
|
|
16
|
|
17
|
Knaup P, Harkener S, Ellsässer KH, Haux R, Wiedemann T. On the necessity of systematically planning clinical tumor documentation. Methods Inf Med 2001; 40:90-8. [PMID: 11424310] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/20/2023]
Abstract
Tumor documentation is an important task for both clinical research and patient care. Documentation systems for these purposes have to be planned systematically and should be goal oriented. We applied the method of a so-called 'standardized documentation protocol' for systematically planning two documentation systems in oncology: one for the tumor center Heidelberg/Mannheim and the other for a nationwide project in the field of documentation and therapy planning in pediatric oncology. The method proved to be helpful in both cases even though the resulting documentation protocols are completely different and although they served different objectives. Therefore, the aim of the paper is to motivate and help medical informatics professionals to systematically plan other documentation systems using this method.
Collapse
Affiliation(s)
- P Knaup
- University of Heidelberg, Institute of Medical Biometry and Informatics, Department of Medical Informatics, Heidelberg.
| | | | | | | | | |
Collapse
|
18
|
Merzweiler A, Knaup P, Creutzig U, Ehlerding H, Haux R, Mludek V, Schilling FH, Weber R, Wiedemann T. Requirements and design aspects of a data model for a data dictionary in paediatric oncology. Stud Health Technol Inform 2001; 77:696-700. [PMID: 11187643] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
Abstract
German children suffering from cancer are mostly treated within the framework of multicentre clinical trials. An important task of conducting these trials is an extensive information and knowledge exchange, which has to be based on a standardised documentation. To support this effort, it is the aim of a nationwide project to define a standardised terminology that should be used by clinical trials for therapy documentation. In order to support terminology maintenance we are currently developing a data dictionary. In this paper we describe requirements and design aspects of the data model used for the data dictionary as first results of our research. We compare it with other terminology systems.
Collapse
Affiliation(s)
- A Merzweiler
- University of Heidelberg, Department of Medical Informatics, Heidelberg, Germany
| | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Knaup P, Mludek V, Wiedemann T, Bauer J, Haux R, Kim L, Schilling F, Selle B. Integrating specialized application systems into hospital information systems--obstacles and factors for success. Stud Health Technol Inform 2001; 77:890-4. [PMID: 11187682] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
Abstract
Hospital information systems are often huge and heterogeneous systems. To support physicians with their daily clinical work, application systems are developed which are dedicated to particular medical fields or tasks and which have to be integrated into the hospital information system. The integration process is quite complicated, because it makes the information system's infrastructure even more heterogeneous. We developed an application system for documentation and therapy planning in pediatric oncology (DOSPO) and we started to introduce it into the Department of Pediatric Oncology of Heidelberg University Hospital. The fact that DOSPO is developed as a universal system for nationwide use made the integration process more difficult. In any case, the introduction of specialized application systems has to be planned systematically in advance, regarding the prevailing information system's infrastructure, available resources and established processes. To simplify the integration process comprehensive electronic patient records for the future should be designed in a way that they can be enhanced easily by new clinical functions.
Collapse
Affiliation(s)
- P Knaup
- University of Heidelberg, Institute for Medical Biometry and Informatics, Department of Medical Informatics, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany
| | | | | | | | | | | | | | | |
Collapse
|
20
|
Merzweiler A, Knaup P, Weber R, Ehlerding H, Haux R, Wiedemann T. Recording clinical data--from a general set of record items to case report forms (CRF) for clinics. Stud Health Technol Inform 2001; 84:653-7. [PMID: 11604818] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/17/2023]
Abstract
Standardising a documentary language makes only sense if we use it for documentation consequently. Using an example of Paediatric Oncology in Germany we have developed a procedure that generates CRFs from a documentary language. The introduced procedure has proved to be feasible in practice. With it we can support developers of documentation systems in creating their CRFs; through the guaranteed use of the documentation terminology we further achieve that information recorded with the created CRFs may be statistically analysed across different institutions.
Collapse
Affiliation(s)
- A Merzweiler
- Institute for Medical Biometry and Informatics, Department of Medical Informatics, University of Heidelberg, 69120 Heidelberg, Germany.
| | | | | | | | | | | |
Collapse
|
21
|
Goppelt-Struebe M, Wiedemann T, Heusinger-Ribeiro J, Vucadinovic M, Rehm M, Pröls F. Cox-2 and osteopontin in cocultured platelets and mesangial cells: role of glucocorticoids. Kidney Int 2000; 57:2229-38. [PMID: 10844593 DOI: 10.1046/j.1523-1755.2000.00083.x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
BACKGROUND Glomerular inflammation is characterized by a consecutive infiltration of immunoreactive cells. To mimic the early phase of glomerular injury, a coculture system of platelets and rat renal mesangial cells was established. As prototypes, the inflammation-related proteins cyclooxygenase-2 (Cox-2) and the chemotactic protein osteopontin (OPN) were investigated. METHODS The expression of OPN and Cox-2 mRNA and protein was determined by Northern and Western blot analyses. RESULTS Coincubation of platelets and mesangial cells led to a rapid, transient induction of Cox-2 mRNA, which peaked at two hours, whereas OPN and monocyte chemoattractant protein-1 (MCP-1) were induced at later time points. The induction of Cox-2 mRNA was concentration dependent and highly reproducible when platelets of different donors were investigated. Partial Cox-2 induction was observed when supernatants of preactivated platelets were incubated with mesangial cells. The inhibition of the signaling pathways of platelet-derived growth factor (PDGF) and epidermal growth factor (EGF) or interference with Gi-protein signaling partially inhibited platelet-induced Cox-2 expression. Down-regulation of protein kinase C (PKC), which is a common signaling module in many pathways leading to Cox-2 induction, almost completely abrogated platelet-induced Cox-2 expression. The time pattern of Cox-2 and OPN expression suggested that Cox-2 might play a role in OPN induction. The up-regulation of OPN was dependent on de novo protein synthesis and was induced by high levels of exogenous prostaglandin E2 (PGE2; 10 micromol/L). Endogenous PGE2, however, proved not to be essential for OPN mRNA expression, because inhibition of Cox activity did not change OPN mRNA levels. Dexamethasone inhibited Cox-2 mRNA induction but increased OPN mRNA and protein expression. CONCLUSION These data indicate that Cox-2 and OPN are independently up-regulated upon interaction of platelets and mesangial cells.
Collapse
Affiliation(s)
- M Goppelt-Struebe
- Medizinische Klinik IV, Universität Erlangen-Nürnberg, Erlangen, and Institut für Anatomie II, Albert-Ludwigs Universität Freiburg, Freiburg, Germany.
| | | | | | | | | | | |
Collapse
|
22
|
Knaup P, Wiedemann T, Wolff A, Creutzig U, Haux R, Schilling FH. [Computer-assisted documentation and therapy planning in pediatric oncology--introduction of a nationwide solution]. Klin Padiatr 1999; 211:189-91. [PMID: 10472547 DOI: 10.1055/s-2008-1043785] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
In Pediatric Oncology in Germany, 90% of the patients are treated according to multicenter clinical trials, which means an enormous effort for documentation in the participating clinics. In order to enable multiple use of data for patient records as well as for clinical trials a computer-based documentation system for pediatric oncology (DOSPO) is being developed, which can be used nationwide. DOSPO currently comprises a minimum basic data set, which represents the common core of all multicenter trials and which has been approved by the German Society for Pediatric Oncology and Hematology (GPOH). It is intended to enhance the documentation by specific items of each clinical trial. Functions for computer-aided chemotherapy planning and medical report writing have already been implemented in the documentation system. Various centers in Germany are currently validating the system in routine use.
Collapse
Affiliation(s)
- P Knaup
- Abteilung Medizinische Informatik, Universität Heidelberg.
| | | | | | | | | | | |
Collapse
|
23
|
Wiedemann T, Knaup P, Bachert A, Creutzig U, Haux R, Schilling F. Computer-aided documentation and therapy planning in pediatric oncology. Stud Health Technol Inform 1999; 52 Pt 2:1306-9. [PMID: 10384671] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/13/2023]
Abstract
In the past 20 years considerable progress was made in pediatric oncology concerning the results of therapy in Germany. Nationwide multicentre trials provide protocols for the therapy of the children. The calculation of the chemotherapy according to the protocols is rather complex and the documentation efforts for the pediatricians are enormous. Thus, we developed as a first step an application system for Computer Aided Therapy Planning In Pediatric Oncology (CATIPO), that is in routine use in about 20 pediatric clinics in Germany. In order to support the physician comprehensively with the documentation that is necessary for the trials we currently develop a Documentation System for Pediatric Oncology (DOSPO) that comprises the functionality of chemotherapy planning according to the protocols released by the trial centres. Besides supporting the physician in clinical routine the major objective is to improve the quality of the documented data. To reach this aims DOSPO combines research aspects of decision support and clinical documentation: formal representation of general protocols, calculating of a particular therapy for a patient, data acquisition, communication interfaces for transferring the data to the trial centres. In order to support trial centres an authoring system and a central data dictionary will be developed. This will enable the trial centres to develop new modules for trial-specific data acquisition in the clinics.
Collapse
Affiliation(s)
- T Wiedemann
- University of Heidelberg, Department of Medical Informatics, Germany.
| | | | | | | | | | | |
Collapse
|
24
|
Mertz DP, Koller PU, Vollmar J, Wiedemann T. [Effect of anthropometric factors on serum concentration of uric acid. Studies on 300 unselected ambulant outpatients (author's transl)]. Med Klin 1974; 69:1297-1303. [PMID: 4427563] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
|